Table 1.
Basic demographic data of included patients by diagnostic category
| Basic clinical data | Study population (n=237) | MS patients (n=186, 78.48%) | CIS (n=19, 8.02%) | NMO (n=12, 5.06%) | ADEM (n=10, 4.22%) | Unclassified (n=10, 4.22%) |
|---|---|---|---|---|---|---|
| Gender (F/M) | 153/84 (1.82:1) | 115/71 (1.62:1) | 11/8 (1.38:1) | 7/5 (1.40:1) | 6/4 (1.50:1) | 7/3 (2.33:1) |
| Age at disease onset (years) | ||||||
| Range; mean (SD) | 6–18; 14.14 (2.45) | 6–18; 14.13 (2.49) | 7–18; 14.88 (2.01) | 8–18; 14.44 (1.88) | 6–15; 12.21 (2.73) | 6–15; 13.35 (2.41) |
| Median (IQR) | 14.5 (13–16) | 14.5 (13–16) | 15 (13–17) | 14.5 (13–16) | 12.5 (10–14) | 12 (10–14) |
| Age at diagnosis (years) | ||||||
| Range; mean (SD) | 6–19; 14.77 (2.53) | 6–19; 14.74 (2.54) | 7–18; 15.35 (2.04) | 8–19; 15.81 (2.32) | 6–15; 13.91 (2.88) | |
| Median (IQR) | 15 (13.5–16.5) | 15 (13–16) | 15 (13–17) | 15.5 (13.5–17) | 12.5 (10–14) | |
| Disease duration at time of data collection (months) | ||||||
| Range; mean (SD) | 1–248; 21.63 (28.71) | 1–248; 23.40 (32.02) | 2–49; 13.71 (11.05) | 7–75; 20.67 (15.85) | 7–18; 13.51 (7.07) | 9–20; 12.41 (4.83) |
| Median (IQR) | 13 (9–22) | 13 (9–22) | 10 (6.5–16.5) | 18 (8.5–19.5) | 9 (7.5–16.5) | 11 (9–16.25) |
Abbreviations: ADEM, acute disseminated encephalomyelitis; CIS, clinically isolated syndrome; F, Female; IQR, interquartile range; M, Male; MS, multiple sclerosis; NMO, neuromyelitis optica.